source
- Eli Lilly, Novo, AbbVie and Boehringer showcase new obesity drug data at European meetingThe European Association for the Study of Diabetes held its annual meeting in Milan, drawing obesity and metabolic disease experts and providing a platform for drugmakers to present emerging weight…
- Sanofi, Regeneron expand partnership with $1 billion deal to develop next-generation Dupixent-like antibodiesSanofi and Regeneron announced they have broadened their long‑standing alliance, adding a $1 billion upfront payment to fund joint work on new immune‑modulating drugs. The revised agreement calls…